| 1 |
27207449 | Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study. | 2017 Feb |
3 |
| 2 |
27683214 | Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review. | 2016 Sep 29 |
2 |
| 3 |
24990854 | Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS). | 2015 Jan |
2 |
| 4 |
25557371 | Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis. | 2015 Apr |
6 |
| 5 |
25750916 | Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials. | 2015 Feb |
1 |
| 6 |
24989666 | Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study. | 2014 Sep |
4 |
| 7 |
25270680 | Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study. | 2014 Dec |
1 |
| 8 |
25315404 | Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies. | 2014 Dec 1 |
1 |